Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 09-2005 | 06-2005 | 03-2005 | 12-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -71,611 | -50,128 | -31,669 | -14,662 | -52,489 |
| Depreciation Amortization | 2,668 | 1,946 | 1,347 | 734 | 4,117 |
| Accounts receivable | -1,070 | 218 | -373 | 235 | -118 |
| Accounts payable and accrued liabilities | 1,812 | -759 | -871 | -1,039 | 997 |
| Other Working Capital | 9,374 | 5,700 | 4,026 | 1,237 | -7,327 |
| Other Operating Activity | -208 | 1,325 | 1,585 | 1,136 | 4,708 |
| Operating Cash Flow | $-59,035 | $-41,698 | $-25,955 | $-12,359 | $-50,112 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,395 | -8,166 | -10,059 | -5,881 | -12,957 |
| PPE Investments | -2,570 | -1,193 | -393 | -56 | -619 |
| Investing Cash Flow | $-1,175 | $-9,359 | $-10,452 | $-5,937 | $-13,576 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,500 | 1,500 | 1,500 | 1,500 | 2,600 |
| Debt Repayment | -4,875 | -3,800 | -2,682 | -1,640 | -7,341 |
| Common Stock Issued | 84,347 | 69,905 | 68,708 | 68,593 | 71,789 |
| Other Financing Activity | 191 | 191 | 0 | 0 | 310 |
| Financing Cash Flow | $81,163 | $67,796 | $67,526 | $68,453 | $67,358 |
| Beginning Cash Position | 16,811 | 16,811 | 16,811 | 16,811 | 13,141 |
| End Cash Position | 37,764 | 33,550 | 47,930 | 66,968 | 16,811 |
| Net Cash Flow | $20,953 | $16,739 | $31,119 | $50,157 | $3,670 |
| Free Cash Flow | |||||
| Operating Cash Flow | -59,035 | -41,698 | -25,955 | -12,359 | -50,112 |
| Capital Expenditure | -2,570 | -1,193 | -393 | -56 | -664 |
| Free Cash Flow | -61,605 | -42,891 | -26,348 | -12,415 | -50,776 |